GrayJAPatnickJBlanksRG.Maximising benefit and minimising harm of screening. BMJ. 2008;336(7642):480-483. doi:10.1136/bmj.39470.643218.94
2.
WilsonJMJungnerYG.Principios y metodos del examen colectivo para identificar enfermedades [Principles and practice of mass screening for disease]. Bol Oficina Sanit Panam. 1968;65(4):281-393.
3.
JorgensenTRotarOJuhlCLinnebergA.What is the Effectiveness of Systematic Population-Level Screening Programmes for Reducing the Burden of Cardiovascular Diseases? (WHO health evidence network synthesis report, 78). 2nd ed.WHO; 2024.
4.
KoppH.Radiation damage caused by shoe-fitting fluoroscope. Br Med J. 1957;2(5057):1344-1345. doi:10.1136/bmj.2.5057.1344
5.
YuillSNaiduCSmithM, et al. Cervical cancer elimination in Australia and the Asia Pacific: progress and barriers. Med J Aust. 2026;224(4):e70164. doi:10.5694/mja2.70164
6.
SasieniPFalcaroM.Cervical cancer mortality trends following HPV vaccination in England, 2001-24: an analysis of population-based mortality data. Lancet. Published online June 17, 2026. doi:10.1016/S0140-6736(26)00918-9
7.
RosenfeldL.Clinical chemistry since 1800: growth and development. Clin Chem. 2002;48(1):186-197.
8.
ArmbrusterDAOvercashDRReyesJ.Clinical chemistry laboratory automation in the 21st century – Amat Victoria curam (Victory loves careful preparation). Clin Biochem Rev. 2014;35(3):143-153.
9.
DavenportMSReederSB.Elective MRI screening of the general public-buyer beware. JAMA. 2026;335(21):1839-1840. doi:10.1001/jama.2026.5888
10.
GuppyMTracyMBuchbinderR.Overdiagnosis and overtesting. Aust J Gen Pract. 2026;55(6):329-331. doi:10.31128/AJGP-11-25-7893
